Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FXKPR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $248,316
Award facts
- Contract value 100% obligated
- $248,315.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $248,315.50 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (urate oxidase, 30-count units) on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier to federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order will be performed at the company's Conshohocken location.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp as one of several key vendors in this strategic approach to federal pharmaceutical supply chain management.
Quick answers
Who was awarded contract SPE2DB25FXKPR?
SPE2DB25FXKPR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FXKPR worth?
The government has obligated $248,316 on SPE2DB25FXKPR.
Is contract SPE2DB25FXKPR an order under another contract?
Yes. SPE2DB25FXKPR is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXKPR competed?
The extent of competition for SPE2DB25FXKPR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award